Testing method using transgenic mice expressing an oncogene
AssigneePresident and Fellows of Havard College
InventorsPhilip Leder, Timothy A. Stewart
Life of this patent
Estimating the term…
Abstract
A transgenic non-human eukaryotic animal whose germ cells and somatic cells contain an activated oncogene sequence introduced into the animal, or an ancestor of the animal, at an embryonic stage.
Claims3
A method of testing a material suspected of being a carcinogen, comprising exposing a transgenic mouse to said material and detecting neoplasms as an indication of carcinogenicity, wherein the germ cells and somatic cells of said mouse contain an activated oncogene sequence introduced into said mouse, or an ancestor of said mouse, at an embryonic stage.
A method of testing a material suspected of conferring protection against the development of neoplasms, said method comprising
- (1) providing a first and a second transgenic mouse, the germ cells and somatic cells of which contain an activated oncogene sequence introduced into said mice, or an ancestor of said mice, at an embryonic stage,
- (2) treating said first mouse with said material, and
- (3) detecting, as an indication of said protection, a reduced incidence of development of neoplasms in said first mouse, compared to the incidence in said second mouse, which is not so treated.
Dependencies are inferred from the claim text.